Health

Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.

Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.

Scholars argue that increased use of direct-to-consumer genetic testing creates hidden privacy risks.

States should learn from each other to confront the challenges of regulating marijuana.

Scholars urge regulators to help level the playing field in contracting between health plans and hospitals.

States should shift incentives to reduce nonmedical exemptions while respecting the choice not to vaccinate.

The Trump Administration encourages states to use “innovation waivers” to find new ways to lower costs.

Regulation of marijuana has been based on a false distinction for almost a century.

HIPAA does not stop health care providers from disclosing patient information to provide better care.

The Right to Try Act represents an important step toward helping dying patients with little recourse.

A flock of regulators and industry representatives have a seat at the turkey-regulating table.

Scholars argue that OSHA could make the “workplace” for professional football players safer.